OR WAIT null SECS
April 09, 2019
Catalent invests $5 million in hot melt extrusion capabilities at Somerset, NJ facility.
April 02, 2019
The partnership will enable the Applied Process Company (APC) and the National Institute for Bioprocessing Research & Training (NIBRT) to provide increased access to R&D and analytical services.
More work needed to advance drug design and development effectively.
March 20, 2019
Catalent announces investment for its Zydis ODT technology, offering increased drug load and taste-masking capabilities.
March 19, 2019
A $100-million investment will expand a range of the CDMO’s service capabilities and offerings.
March 18, 2019
The expansion includes a new R&D laboratory and the installation of a 12,000-liter reactor at one of the company’s manufacturing facilities on its Paullo site in Milan, Italy.
February 04, 2019
Keeping abreast of the latest industry trends and retaining flexibility are key to maintaining a strong market position.
February 02, 2019
Novel analytical methods may help biologics manufacturers respond to stricter regulations on particulate matter.
February 01, 2019
Tech transfer is key to succession advancing biopharmaceutical pipeline products from research to preclinical.
Outsourcing of analytical testing and processes can help bio/pharmaceutical companies expand their product profiles.